IBEX Reports Record Start to Fiscal 2026, Raises Full Year Guidance

(NasdaqGM:IBEX), Record first quarter Revenue, Adjusted EBITDA, EPS, Adjusted EPS, and Free Cash Flow Revenue grew 16.5% versus prior year quarter EPS grew 91% year-over-year to $0.82 and adjusted EPS grew 74% to $0.90 Raises Fiscal Year Guidance WASHINGTON, Nov. 06, 2025 (GLOBE NEWSWIRE) — IBEX Limited (“ibex”) (Nasdaq: IBEX), a leading provider in global […]

Trupanion Reports Strong Third Quarter 2025 Results and Secures New Credit Facility

(NasdaqGM:TRUP),(NYSE:PNC), SEATTLE, Nov. 06, 2025 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2025. “We delivered record quarterly profitability while accelerating subscription pet growth for the third consecutive quarter,” said Margi Tooth, Chief Executive Officer

Giga Metals Completes Final Tranche of Upsized Private Placement

Giga Metals Completes Final Tranche of Upsized Private Placement GlobeNewswire November 06, 2025 NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 06, 2025 (GLOBE NEWSWIRE) — Scott Lendrum, CEO of Giga Metals Corp. (“Giga Metals” or the “Company”) (TSX-V: GIGA; OTCQB: GIGGF; FSE: BRR2) is pleased to

Century Aluminum Company Reports Third Quarter 2025 Results

Century Aluminum Company Reports Third Quarter 2025 Results GlobeNewswire November 06, 2025 CHICAGO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Century Aluminum Company (NASDAQ: CENX) today announced its third quarter 2025 results. Third Quarter 2025 Financial Results $MM (except shipments and per share data) Q3 2025 Q2 2025 Aluminum shipments (tonnes) 162,442 175,741 Net sales $

Crinetics Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Crinetics Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 06, 2025 PALSONIFY(TM) (Paltusotine) Launched in the U.S. with Encouraging Early Feedback from Patients and Physicians, and Positive Reimbursement Trends Reiterates Cash Burn of $340-370M and Cash Runway into 2029 Management Hosting Conference Call at 4:30 p.m. ET Today SAN DIEGO,

TTEC Announces Third Quarter 2025

(NASDAQ:TTEC), Third Quarter 2025 Revenue was $519.1 Million Net Loss was $11.1 Million or negative 2.1 Percent of Revenue(Net Income of $5.9 Million or 1.1 Percent of Revenue Non-GAAP) Adjusted EBITDA was $43.4 Million or 8.4 Percent of Revenue Reiterates Outlook for Full Year 2025Announces Term Extension of Credit Facility AUSTIN, Texas, Nov. 06, 2025

WillScot Reports Third Quarter 2025 Results and Updates 2025 Full Year Outlook

WillScot Reports Third Quarter 2025 Results and Updates 2025 Full Year Outlook GlobeNewswire November 06, 2025 SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) — WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced third quarter 2025 results, including key performance highlights and market updates, and an

Treace Medical Concepts Reports Third Quarter 2025 Financial Results

(NASDAQ:TMCI), PONTE VEDRA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights Generated revenue of

Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development

Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development GlobeNewswire November 06, 2025 – Rapidly advancing NXT-41x to address significant unmet medical need for plastic and reconstructive surgery, which represents an estimated $1.5 billion U.S. market opportunity Conference call today at 5:00 p.m.

The Joint Corp. Reports Third Quarter 2025 Financial Results

The Joint Corp. Reports Third Quarter 2025 Financial Results GlobeNewswire November 06, 2025 – Grew Revenue 6%, Compared to Third Quarter 2024 – – Board Authorizes an Additional $12 Million for Share Repurchases – SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic

Scroll to Top